Deprescribing of non-antiretroviral therapy in HIV-infected patients
- 21 December 2019
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 76 (3) , 305-318
Abstract
In recent decades, the life expectancy of HIV-infected patients has increased considerably, to the extent that the disease can now be considered chronic. In this context of progressive aging, HIV-infected persons have a greater prevalence of comorbid conditions. Consequently, they usually take more non-antiretroviral drugs, and their drug therapy are more complex. This supposes a greater risk of drug interactions, of hospitalization, falls, and death. In the last years, deprescribing has gained attention as a means to rationalize medication use.Keywords
This publication has 101 references indexed in Scilit:
- The Next Therapeutic Challenge in HIV: PolypharmacyDrugs & Aging, 2013
- Polypharmacy in the HIV-infected older adult populationClinical Interventions in Aging, 2013
- Serious Non-AIDS events: Immunopathogenesis and interventional strategiesAIDS Research and Therapy, 2013
- Inappropriateness of Medication Prescriptions to Elderly Patients in the Primary Care Setting: A Systematic ReviewPLOS ONE, 2012
- Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naïve HIV patientsInternational Journal of STD & AIDS, 2012
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trialsThe Lancet, 2012
- Polypharmacy Status as an Indicator of Mortality in an Elderly PopulationDrugs & Aging, 2009
- Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General PopulationArchives of internal medicine (1960), 2009
- Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐AnalysisClinical Infectious Diseases, 2009
- Medication Withdrawal Trials in People Aged 65 Years and OlderDrugs & Aging, 2008